Chime Bio, flush with $190M, blueprints major biomanufacturing boost in China

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Apr 6, 2021 at 10:52 AM.

  1. #1 cafead, Apr 6, 2021 at 10:52 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,024
    Likes Received:
    3
    via After locking up a $125 million Series A in early 2020, China-based CDMO Chime Biologics has raised another $65 million to help build and kit out a second plant in Wuhan, China.

    The $190 million investment will fuel an expansion over the next five years at its site in Wuhan, taking capacity there to 140,000 liters.

    article source
     
    Quote

Reply to Thread